Simplex Trading’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,305
| Closed | -$49.2K | – | 9832 |
|
|
2025
Q3 | $36K | Buy |
+1,305
| New | +$39K | ﹤0.01% | 6784 |
|
|
2024
Q3 | – | Sell |
-136
| Closed | -$1.6K | – | 9403 |
|
|
2024
Q2 | $1K | Sell |
136
-118
| -46% | -$1.24K | ﹤0.01% | 8552 |
|
|
2024
Q1 | $3K | Buy |
+254
| New | +$3.42K | ﹤0.01% | 8303 |
|
|
2022
Q4 | – | Sell |
-8,385
| Closed | -$76.9K | – | 10218 |
|
|
2022
Q3 | $98K | Buy |
+8,385
| New | +$113K | ﹤0.01% | 5567 |
|
|
2022
Q2 | – | Sell |
-6,412
| Closed | -$129K | – | 10903 |
|
|
2022
Q1 | $191K | Sell |
6,412
-2,426
| -27% | -$65.7K | ﹤0.01% | 5220 |
|
|
2021
Q4 | $234K | Buy |
8,838
+2,933
| +50% | +$88.5K | ﹤0.01% | 4950 |
|
|
2021
Q3 | $265K | Sell |
5,905
-640
| -10% | -$25.2K | ﹤0.01% | 5107 |
|
|
2021
Q2 | $284K | Sell |
6,545
-2,921
| -31% | -$110K | ﹤0.01% | 5072 |
|
|
2021
Q1 | $323K | Buy |
9,466
+758
| +9% | +$30K | ﹤0.01% | 4054 |
|
|
2020
Q4 | $304K | Buy |
8,708
+5,509
| +172% | +$159K | ﹤0.01% | 4055 |
|
|
2020
Q3 | $76K | Buy |
+3,199
| New | +$78.5K | ﹤0.01% | 5196 |
|
|
2020
Q2 | – | Sell |
-330
| Closed | -$5.94K | – | 8233 |
|
|
2020
Q1 | $5K | Sell |
330
-6,044
| -95% | -$129K | ﹤0.01% | 6869 |
|
|
2019
Q4 | $136K | Buy |
6,374
+2,210
| +53% | +$45.5K | ﹤0.01% | 4172 |
|
|
2019
Q3 | $77K | Buy |
+4,164
| New | +$86K | ﹤0.01% | 4599 |
|
|
2019
Q1 | – | Sell |
-3,077
| Closed | -$70.3K | – | 7731 |
|
|
2018
Q4 | $70K | Buy |
3,077
+2,079
| +208% | +$58.7K | ﹤0.01% | 4200 |
|
|
2018
Q3 | $32K | Buy |
+998
| New | +$30K | ﹤0.01% | 5590 |
|
|
2018
Q2 | – | Sell |
-1,802
| Closed | -$64.1K | – | 7806 |
|
|
2018
Q1 | $63K | Buy |
1,802
+1,167
| +184% | +$46.7K | ﹤0.01% | 2205 |
|
|
2017
Q4 | $24K | Buy |
+635
| New | +$24.2K | ﹤0.01% | 3140 |
|
|
2017
Q3 | – | Sell |
-1,194
| Closed | -$29K | – | 6511 |
|
|
2017
Q2 | $32K | Buy |
+1,194
| New | +$32.7K | ﹤0.01% | 2812 |
|
|
2016
Q4 | – | Sell |
-497
| Closed | -$14.2K | – | 6409 |
|
|
2016
Q3 | $18K | Sell |
497
-5,413
| -92% | -$155K | ﹤0.01% | 3081 |
|
|
2016
Q2 | $131K | Buy |
5,910
+4,486
| +315% | +$112K | 0.01% | 1286 |
|
|
2016
Q1 | $29K | Buy |
+1,424
| New | +$35.1K | ﹤0.01% | 2460 |
|
|
2015
Q4 | – | Sell |
-23
| Closed | -$697 | – | 6017 |
|
|
2015
Q3 | $0 | Sell |
23
-150
| -87% | -$4.48K | ﹤0.01% | 6079 |
|
|
2015
Q2 | $5K | Sell |
173
-201
| -54% | -$7.68K | ﹤0.01% | 3674 |
|
|
2015
Q1 | $13K | Buy |
374
+373
| +37,300% | +$10.2K | ﹤0.01% | 2705 |
|
|
2014
Q4 | $0 | Buy |
+1
| New | +$20 | ﹤0.01% | 4653 |
|
Other funds holding RIGL
AC
VCM
Simplex Trading's RIGL Position: Q4 2025 in Review
Simplex Trading sold out of Rigel Pharmaceuticals (RIGL) in Q4 2025, closing a stake of 1,305 shares — an estimated $49.2K sold.
Simplex Trading first reported a position in RIGL in Q4 2014 and held it in 26 quarters. The position peaked at $323K in Q1 2021. 193 funds tracked by Wall St. Rank hold RIGL as of Q4 2025.
- Simplex Trading reported no remaining Rigel Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 1,305 Rigel Pharmaceuticals shares in Q4 2025, an estimated $49.2K.
- Simplex Trading first reported a position in Rigel Pharmaceuticals in Q4 2014 and held it in 26 quarters.
- Simplex Trading's Rigel Pharmaceuticals position peaked at $323K in Q1 2021.
- 193 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.